Vaccine Shows Promise Against a Range of Cancers
By Serena Gordon HealthDay Reporter MONDAY, Oct. 1, 2018 (HealthDay News) — A personalized vaccine held an aggressive group of cancers in check among more than half of patients who received it in a small, preliminary trial, researchers report. HER2-positive cancers are cancers that have too much of the HER2 protein on their surface. In… Read More »